United StatesLiraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, manufactured for Lupin Pharmaceuticals and produced by Lupin Limited, sold as 2-pen (NDC 70748-346-02) and 3-pen (NDC 70748-346-03) pen injectors in lots WB00097, WB00094, WB00088 (exp. Jul 2027); WB00103 (exp. Oct 2027); WC00016 (exp. Dec 2027); WB00098, WB00092, WB00093 (exp. Jul 2027); WB00104, WB00105, WB00106 (exp. Oct 2027). It was recalled because of the presence of particulate matter described as a white thread-like structure in the cartridge; 217,621 pen injectors were distributed nationwide in the U.S.
What's being recalled
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Recalling firm: Lupin Pharmaceuticals Inc., Naples, FL, United States.
How to identify it
Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.
The hazard
Presence of particulate matter: a white thread-like structure in the cartridge
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within U.S
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)